Skip to main content
66°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.32
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >
Is Now a Good Time to Buy the Dip on Pfizer?
February 09, 2025
Via
The Motley Fool
3 Dividend Stocks to Double Up on Right Now
February 09, 2025
Via
The Motley Fool
10 Undervalued Hidden Gem Dividend Stocks For Savvy Investors
February 07, 2025
Income investors should focus on higher-yielding securities, if they want additional income from their stock portfolios.
Via
Talk Markets
Topics
Stocks / Equities
Most active S&P500 stocks in Thursday's session
February 06, 2025
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Thursday. Discover the stocks that are generating the highest...
Via
Chartmill
Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.
February 06, 2025
The company won three FDA approvals over the past two years. Now, it's angling for two new approvals in 2025.
Via
Investor's Business Daily
Unpacking the Latest Options Trading Trends in Pfizer
February 04, 2025
Via
Benzinga
What Drives Billionaire Masayoshi Son?
February 05, 2025
The man behind SoftBank has now teamed up with OpenAI to invest up to $500 billion in American AI infrastructure over the next four years.
Via
The Motley Fool
Topics
Artificial Intelligence
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q4 Results Tomorrow
February 05, 2025
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results tomorrow before the bell. Here’s what you need to know.
Via
StockStory
What To Expect From Eli Lilly’s (LLY) Q4 Earnings
February 05, 2025
Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting results tomorrow morning. Here’s what to expect.
Via
StockStory
Looking for the most active stocks in the S&P500 index on Tuesday?
February 04, 2025
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Tuesday and discover the stocks that are dominating the trading activity and setting the pace for...
Via
Chartmill
Pfizer (PFE) Q4 2024 Earnings Call Transcript
February 04, 2025
PFE earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Pfizer Shares Are Falling Today: What's Going On?
February 04, 2025
Pfizer Inc. (NYSE: PFE) shares are trading lower Tuesday after the Senate Finance Committee voted to advance Robert F. Kennedy Jr.'s nomination for Secretary of Health and Human Services.
Via
Benzinga
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
February 04, 2025
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.
Via
Benzinga
Pfizer's Retail Traders Cheer Better-Than-Expected Q4 Even As Stock Dips: ‘Another Beat And Still Crazy Cheap'
February 04, 2025
Under its restructuring program, Pfizer said it remains on track to deliver $4.5 billion in cost savings by the end of 2025.
Via
Stocktwits
RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.
February 04, 2025
RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines in favor of his nomination.
Via
Investor's Business Daily
Nasdaq Surges Over 1%; Pfizer Earnings Top Estimates
February 04, 2025
Via
Benzinga
Robert F. Kennedy's Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Drop
February 04, 2025
The U.S. Senate Finance Committee on Tuesday voted 14 to 13 in favor of advancing the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Benzinga
Pfizer Beats Q4 Revenue, EPS Estimates
February 04, 2025
Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings.
Via
The Motley Fool
Pfizer Q4 Earnings: Revenue And EPS Beat, Seagen And COVID-19 Products Show Strength, Issues Strong FY25 Outlook
February 04, 2025
Pfizer posted Q4 revenue of $17.76 billion, up 22% YoY, with strong sales from Paxlovid, Vyndaqel, and Eliquis. The company reaffirmed its 2025 revenue outlook.
Via
Benzinga
Pfizer Edges Higher As Covid Sales Decline, But Still Beat Expectations
February 04, 2025
Pfizer stock rose moderately early Tuesday on the back of its quarterly beat.
Via
Investor's Business Daily
Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4
February 04, 2025
Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 21.9% year on year to $17.76 billion. On the other hand, the...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Pfizer Reports Better Than Expected Q4 Results
February 04, 2025
Pfizer Inc. reported a strong performance for the fourth quarter of 2024, with revenues reaching $17.8 billion.
Via
Talk Markets
Topics
Stocks / Equities
Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance
February 04, 2025
From
Pfizer Inc.
Via
Business Wire
US Stocks Likely To Open Lower As Trump's Trade War Continues To Impact The Market: 'Volatility Is The Toll We Pay To Invest,' Says Expert
February 04, 2025
U.S. stock futures were trading lower on Tuesday after Monday's decline as the new administration tariffs continued to spook the market.
Via
Benzinga
Topics
Government
World Trade
2 Ultra-High-Yield Dividend Stocks That Are No-Brainer Buys in February
February 04, 2025
These sensational income stocks -- sporting an average yield of 6.15% -- can fatten investors' pocketbooks for a long time to come.
Via
The Motley Fool
Dow Trims Losses After Trump Delays Mexico, Canada Tariffs: Greed Index Remains In 'Fear' Zone
February 04, 2025
Via
Benzinga
Topics
Government
Stocks
Pfizer Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 04, 2025
Via
Benzinga
Earnings Scheduled For February 4, 2025
February 04, 2025
Via
Benzinga
PepsiCo, Pfizer And 3 Stocks To Watch Heading Into Tuesday
February 04, 2025
US stock futures down on Tues, focus on PepsiCo, NXP Semiconductors, Pfizer earnings. UBS reports strong Q4, EA to release after market close.
Via
Benzinga
Here’s What NOT to Do the Next Time Tariffs Hit
February 03, 2025
Worried about market drops and tariff news? Discover why short-term volatility shouldn’t derail your long-term investing strategy, with lessons from Amazon and other market giants. Stay focused on...
Via
InvestorPlace
Topics
World Trade
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.